Praxis Precision Medicines (PRAX) Cash from Operations (2019 - 2026)
Praxis Precision Medicines (PRAX) recorded quarterly Cash from Operations of 86152000.0 in Q1 2026, down 12.88% quarter-over-quarter from 76325000.0 in Q4 2025, and down 62.52% on a YoY basis from 229862971.61 in Q1 2025.
Praxis Precision Medicines (PRAX) Cash from Operations (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Cash from Operations history runs 8 years deep, the most recent figure standing at 86152000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 62.52% year-over-year to 86152000.0; the TTM figure through Mar 2026 stood at 282210000.0 (down 72.17% YoY), while the FY2025 annual figure was 249068000.0, down 89.04% from the prior year.
- Cash from Operations was 86152000.0 for Q1 2026 at Praxis Precision Medicines, down from 76325000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 20857000.0 in Q1 2024 to a low of 86152000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 44891529.41 across 5 years, with a median of 44919000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations jumped 48.32% in 2023, then sank 154.16% in 2025.
- A 5-year view of Cash from Operations shows it stood at 28806000.0 in 2022, then rose by 17.17% to 23861000.0 in 2023, then tumbled by 135.2% to 56122000.0 in 2024, then sank by 36.0% to 76325000.0 in 2025, then retreated by 12.88% to 86152000.0 in 2026.
- The last three Cash from Operations figures came in at 86152000.0 (Q1 2026), 76325000.0 (Q4 2025), and 65057000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | -86.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.15 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Jun 30, 2025 | -54.68 Mn |
| Mar 31, 2025 | -53.01 Mn |
| Mar 31, 2025 | -53.01 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Dec 31, 2023 | -23.86 Mn |
| Dec 31, 2023 | -23.86 Mn |